Reported results
- Net loss was $33.3 million, or $0.45 per basic and diluted share, for the third quarter of 2026.
- Research and development expenses were $29.5 million for the third quarter of 2026.
- General and administrative expenses were $6.3 million for the third quarter of 2026.
- Cash, cash equivalents, restricted cash, and investments in marketable securities were $216.0 million as of September 30, 2026.
- Non-cash stock-based compensation expense included in research and development expense was $0.7 million for the third quarter of 2026.
- Non-cash stock-based compensation expense included in general and administrative expense was $1.1 million for the third quarter of 2026.
Guidance
- Nkarta expects its current cash and cash equivalents to fund its current operating plan into 2029.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
